Larimar Therapeutics Inc

LRMRNASDAQ NMS - GLOBAL MARKET

Health CareBiotechnology

$3.48

-0.010000 (-0.29%)

As of 05/29/26 EDT · USD

Compare

52-Week Low: $2.12Current: $3.4852-Week High: $6.42

Key Statistics

Open

$3.50

Day High

$3.53

Day Low

$3.43

Prev. Close

$3.49

Volume

1.24M

Avg. Volume

—

Market Cap

$361.51M

P/E (TTM)

-1.69

Forward P/E

—

P/B Ratio

—

52W High

$6.42

52W Low

$2.12

50D MA

$4.30

200D MA

$4.02

Dividend Yield

—

Beta

—

Performance

-2.5%

-19.8%

-5.2%

YTD

+0.3%

+54.7%

About

Friedreich's ataxia (FRDA) is a rare, inherited, autosomal recessive neurodegenerative disorder that primarily affects the nervous system, causing progressive damage to the spinal cord, peripheral nerves, and cerebellum, leading to impaired muscle coordination (ataxia). The condition typically manifests in childhood or adolescence, with initial symptoms including difficulty walking, loss of balance, and poor coordination. As the disease progresses, it can also impact speech, vision, and hearing. Many individuals with Friedreich's ataxia develop scoliosis, diabetes, and hypertrophic cardiomyopathy, a serious heart condition that is a leading cause of mortality in patients.

larimartx.com/